Ebola virus disease
Researchers hopeful experimental antiviral treatment stops Ebola
August 26, 2015Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp
An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …
Encouraging first results from trial of Merck’s Ebola vaccine
July 31, 2015Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination
The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
